...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zacks

Just to check I emailed IR to ask wether we were planning an IPO as a Reason to pay Zacks for the report.Three days and no response. 

Share
New Message
Please login to post a reply